948 reports of this reaction
6.6% of all MICONAZOLE NITRATE reports
#3 most reported adverse reaction
VULVOVAGINAL PAIN is the #3 most commonly reported adverse reaction for MICONAZOLE NITRATE, manufactured by H E B. There are 948 FDA adverse event reports linking MICONAZOLE NITRATE to VULVOVAGINAL PAIN. This represents approximately 6.6% of all 14,417 adverse event reports for this drug.
Patients taking MICONAZOLE NITRATE who experience vulvovaginal pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VULVOVAGINAL PAIN is moderately reported among MICONAZOLE NITRATE users, representing a notable but not dominant share of adverse events.
In addition to vulvovaginal pain, the following adverse reactions have been reported for MICONAZOLE NITRATE:
The following drugs have also been linked to vulvovaginal pain in FDA adverse event reports:
VULVOVAGINAL PAIN has been reported as an adverse event in 948 FDA reports for MICONAZOLE NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VULVOVAGINAL PAIN accounts for approximately 6.6% of all adverse event reports for MICONAZOLE NITRATE, making it one of the most commonly reported side effect.
If you experience vulvovaginal pain while taking MICONAZOLE NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.